Third Rock Ventures V, L.P.

Insider Reports History

Location
Boston, MA
Signature
/s/ Kevin Gillis, Chief Operating Officer of TRV GP V, LLC, general partner of Third Rock Ventures GP V, L.P., general partner of Third Rock Ventures V, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Third Rock Ventures V, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rapport Therapeutics, Inc. 10%+ Owner Common Stock 7.14M $71.2M $9.98 Jun 10, 2024 Direct
Septerna, Inc. 10%+ Owner Common Stock 6.22M $36.4M $5.85 Oct 28, 2024 Direct
CARGO Therapeutics, Inc. 10%+ Owner Common Stock 1.81M $27.1M $15.00 Nov 14, 2023 Indirect
CARGO Therapeutics, Inc. 10%+ Owner Common Stock 1.74M $26.1M $15.00 Nov 14, 2023 Direct
Septerna, Inc. 10%+ Owner Common Stock 3.15M $18.4M $5.85 Oct 28, 2024 Indirect
Rapport Therapeutics, Inc. 10%+ Owner Common Stock 969K $9.67M $9.98 Jun 10, 2024 By Third Rock Ventures VI, L.P.
CARGO Therapeutics, Inc. 10%+ Owner Series A-1 Preferred Stock 0 Nov 14, 2023 Direct
CARGO Therapeutics, Inc. 10%+ Owner Series A-1 Preferred Stock 0 Nov 14, 2023 Indirect
Rapport Therapeutics, Inc. 10%+ Owner Series A Preferred Stock 0 Jun 10, 2024 By Third Rock Ventures VI, L.P.
Rapport Therapeutics, Inc. 10%+ Owner Series A Preferred Stock 0 Jun 10, 2024 Direct
Rapport Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Jun 10, 2024 By Third Rock Ventures VI, L.P.
Septerna, Inc. 10%+ Owner Series A Preferred Stock 0 Oct 28, 2024 Direct
Septerna, Inc. 10%+ Owner Series B Preferred Stock 0 Oct 28, 2024 Indirect

Insider Reports Filed by Third Rock Ventures V, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SEPN Septerna, Inc. Oct 28, 2024 6 $11.7M 4 Oct 28, 2024 10%+ Owner
SEPN Septerna, Inc. Oct 24, 2024 0 $0 3 Oct 24, 2024 10%+ Owner
RAPP Rapport Therapeutics, Inc. Jun 10, 2024 5 $0 4 Jun 10, 2024 10%+ Owner
RAPP Rapport Therapeutics, Inc. Jun 6, 2024 0 $0 3 Jun 6, 2024 10%+ Owner
CRGX CARGO Therapeutics, Inc. Nov 14, 2023 5 $20M 4 Nov 14, 2023 10%+ Owner
CRGX CARGO Therapeutics, Inc. Nov 9, 2023 0 $0 3 Nov 9, 2023 10%+ Owner